U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: April 2-8, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: April 2-8, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 04/04/2023
Location: Virtual
Subject: Human Foods Program Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Food and Beverage Issue Alliance

Event Date: 04/05/2023
Location: Silver Spring, MD
Subject: Retail Foods and Food Safety
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Bob Custard, David Dyjack, Doug Farquhar, Rance Baker (National Environmental Health Association);

Event Date: 04/06/2023
Location: Virtual
Subject: Food Chemicals
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Lillian Zhou, Melanie Benesh, Scott Faber (Environmental Working Group); Tom Neltner (Environmental Defense Fund);

Event Date: 04/06/2023
Location: Virtual
Subject: University of California, San Francisco (UCSF) Department of Medicine; Medical Grand Rounds
FDA Participant/Group: N/A
Non FDA Participant/Group: Faculty, students, and administration of University of California, San Francisco

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 04/04/2023
Location: Silver Spring, MD
Subject: User Fees Discussion
FDA Participant/Group: ANNA FERUS, RAVI BHARWANI, THERESA MULLIN, DOUGLAS SHAFFER, SEMA HASHEMI
Non FDA Participant/Group: Ibrahim Yahaya Oloriegbe (Nigerian Senate Committee on Health); Mojisola Christianah Adeyeye (National Agency for Food and Drug Administration and Control of Nigeria (NAFDAC));

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 04/04/2023
Location: Virtual
Subject: Science Advisory Board and Subcommittee Review Meetings; Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, advocates, and other stakeholders

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 04/03/2023
Location: Silver Spring, MD
Subject: Quality Management and Generic Drug Pricing Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Association for Accessible Medicines (AAM) Chief Executive Officers

Event Date: 04/05/2023
Location: Virtual
Subject: Alliance for a Stronger FDA Webinar; Speaker: CDER Budget Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, media, and other stakeholders

Event Date: 04/06/2023
Location: Virtual
Subject: CDER Research and Public Health Mission Collaboration
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Kip Guy (College of Pharmacy, University of Kentucky); Brookie Best (School of Pharmacy, University of California, San Diego); Peter Swaan (College of Pharmacy, University of Florida); Lawrence Lin (Stanford Center of Excellence in Regulatory Science, University of California, San Francisco); Kathy Giacomini (School of Pharmacy, University of California, San Francisco);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 04/03/2023
Location: Virtual
Subject: Mayo Clinic Symposium on Regenerative Medicine and Surgery 2023; Fireside Chat: Regulatory
FDA Participant/Group: N/A
Non FDA Participant/Group: Research, healthcare, and academia stakeholders

Event Date: 04/04/2023
Location: Virtual
Subject: Alliance for a Stronger FDA Webinar; Speaker: Center for Biologics Evaluation and Research Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, patient groups, industry, and other stakeholders

Event Date: 04/04/2023
Location: Virtual
Subject: World Vaccine Congress 2023; Panelist: What are the Next COVID Vaccines Going to Be? Broad COVID, Broad Corona, or Transmission Blocking Vaccines?
FDA Participant/Group: N/A
Non FDA Participant/Group: Research and industry stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 04/04/2023
Location: Virtual
Subject: Device Shortages
FDA Participant/Group: KIMBERLEE TRZECIAK; HELENE SHERBURNE; TAMMY BECKHAM; ELLEN FLANNERY; JENNIFER TOMASELLO; ELI TOMAR; SUZANNE SCHWARTZ; PAUL AGUILAR;
Non FDA Participant/Group: Sara Maskornick (Office of Senator Bob Casey (D-PA));

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 04/05/2023
Location: Virtual
Subject: FDA's Nutrition Priorities
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Peter Lurie (Center for Science and the Public Interest);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 04/04/2023
Location: Cortland, NY
Subject: The Hitchhiker’s Guide to Tobacco Regulation: Promise and Peril in an Increasingly Complex Landscape and How to Make the Most of Your Undergraduate Experience
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives and students from the State University of New York (SUNY), and Cortland Health Department

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 
Back to Top